Cargando…
Nov/Ccn3, a Novel Transcriptional Target of FoxO1, Impairs Pancreatic β-Cell Function
Type 2 diabetes is characterized by both insulin resistance and progressive deterioration of β-cell function. The forkhead transcription factor FoxO1 is a prominent mediator of insulin signaling in β-cells. We reasoned that identification of FoxO1 target genes in β-cells could reveal mechanisms link...
Autores principales: | Paradis, Renée, Lazar, Noureddine, Antinozzi, Peter, Perbal, Bernard, Buteau, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660386/ https://www.ncbi.nlm.nih.gov/pubmed/23705021 http://dx.doi.org/10.1371/journal.pone.0064957 |
Ejemplares similares
-
NOV story: the way to CCN3
por: Perbal, Bernard
Publicado: (2006) -
Potential cellular conformations of the CCN3(NOV) protein
por: Kyurkchiev, Stanimir, et al.
Publicado: (2004) -
A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis
por: Planque, Nathalie, et al.
Publicado: (2003) -
Matricellular CCN proteins
por: Perbal, Bernard
Publicado: (2008) -
New insight into CCN3 interactions - Nuclear CCN3 : fact or fantasy?
por: Perbal, Bernard
Publicado: (2006)